British study to test mixed vaccine dose schedules in children
Officials are trying to determine the best approach to second doses in adolescents given a small risk of heart inflammation.
China approves first mixed-vaccine trial as Delta spreads
The trial will test the efficacy of combining an 'inactivated' vaccine made by China's Sinovac with a DNA-based one developed by US pharmaceutical company Inovio.